Back
EAPC Premium Access

Considering fatty liver disease as a novel risk factor for cardiovascular outcomes and mortality (cohort study)

Session: Moderated Poster Session II - Epidemiology
Topic: Epidemiology, lipids
Speaker: Professor A. Ryabikov (Novosibirsk, RU)
Event: EuroPrevent 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Andrew Ryabikov

Novosibirsk State Medical University, Novosibirsk (Russian Federation)
0 follower

7 more presentations in this session

Plasma choline and betaine and risk of incident atrial fibrillation: the Hordaland Health Study

Speaker: Doctor H. Zuo (Bergen, NO)

Access
Abstract
Like
Thumbnail

Incidence, treatment, mortality and further outcomes of acute myocardial infarction in the Czech Republic 1992-2012

Speaker: Associate Professor O. Mayer (Pilsen, CZ)

Access
Abstract
Like
Thumbnail

Trends in the risk of early and late-onset heart failure as an adverse outcome of acute myocardial infarction: a CVDNOR project

Speaker: Doctor G. Sulo (Bergen, NO)

Access
Abstract
Like
Thumbnail

Screening for total cholesterol in pharmacies is suitable to identify individuals with high cholesterol levels

Speaker: Ms K. Svendsen (Oslo, NO)

Access
Abstract
Like
Thumbnail

Ten-year changes in the prevalence of healthy lifestyle behaviors and factors among Polish Adults. Results of the National Multicenter Health Surveys WOBASZ (2003-2005) and WOBASZ II (2013-2014).

Access
Like
Thumbnail

Access the full session

Moderated Poster Session II - Epidemiology

Speakers: Professor A. Ryabikov, Doctor H. Zuo, Associate Professor O. Mayer, Doctor G. Sulo, Ms K. Svendsen
Access
Like
Thumbnail

About the event

Image

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources